Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: In vitro and in vivo studies

Journal of Molecular and Cellular Cardiology

Volumn 34, Issue 12, 2002, Pages 1595-1607

  Wu, Semon ^a   Ko, Yu Shien ^a   Teng, Ming Sheng ^a   Ko, Yu Lin ^a   Hsu, Lung An ^a   Hsueh, Chuen ^a   Chou, Yung Yin ^a   Liew, Choong Chin ^b   Lee, Ying Shiung ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adriamycin; Apoptosis; Cardiomyocyte; Endothelial cell

Indexed keywords

ANTIBODY; CASPASE 3; CASPASE INHIBITOR; DNA; DOXORUBICIN; FAS ANTIGEN; FAS LIGAND; PROTEIN BAX; PROTEIN BCL 2; ANTINEOPLASTIC AGENT; BENZYLOXYCARBONYLVALYL ALANYL ASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLVALYL-ALANYL-ASPARTYL FLUOROMETHYL KETONE; CASP3 PROTEIN, HUMAN; CASP3 PROTEIN, RAT; CASPASE; PEPTIDE CHLOROMETHYL KETONE;

ADOLESCENT; AGAR GEL ELECTROPHORESIS; ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASCITES; CONTROLLED STUDY; CORONARY ARTERY; DNA DAMAGE; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; FLOW CYTOMETRY; GENE EXPRESSION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MALE; NEWBORN; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBONUCLEASE PROTECTION ASSAY; SIGNAL TRANSDUCTION; ANIMAL; CARDIOMYOPATHY; CELL CULTURE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENETICS; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; METHODOLOGY; PATHOLOGY; VASCULAR ENDOTHELIUM; WISTAR RAT;

RATTUS NORVEGICUS;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARDIOMYOPATHIES; CASPASE 3; CASPASES; CELLS, CULTURED; DOXORUBICIN; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; MALE; MYOCYTES, CARDIAC; RATS; RATS, WISTAR;

EID: 0036901361     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2002.2110     Document Type: Article

References (31)

1. Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N Eng J Med 1998: 339: 900-905.
2. Gewitz DA. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 1999: 57: 727-741.
3. Minotti G, Cairo G, Monti E. Role of iron in anthracycline cardiotoxicity: New tunes for an old song? FASEB J 1999: 13: 199-212.
4. Kumar D, Kirshenbaum LA, LI T, Danelisen I, Singal PK. Apoptosis in adriamycin cardiomyopathy and its modulation by probucol. Antioxid Redox Signal 2001: 3: 135-145.
5. Rabelo E, DE Angeles K, Bock P, Fernandes TG, Cervo F, Klein AB, Clausell N, Irigoyen MC. Baroreflex sensitivity and oxidative stress in adriamycin-induced heart failure. Hypertension 2001; 38: 576-580.
6. Choy JC, Granville DJ, Hunt DWC, Mcmanus BM. Endothelial cell apoptosis: Biochemical characteristics and potential implications for atherosclerosis. J Mol Cell Cardiol 2001; 33: 1672-1690.
7. Rezvani M, Barrans JD, Dai KS, Liew CC. Apoptosis-related genes expressed in cardiovascular development and disease: An EST approach. Cardiovasc Res 2000: 45: 621-629.
8. Auner HW, Tinchon C, Linkesch W, Halwachsbaumann G, Sill H. Correspondence re: O. J. Arola et al., acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res 2000: 60: 1789-1792, Cancer Res 2001; 61: 2335-2336.
9. Auner HW, Tinchon C, Linkesch W, Halwachsbaumann G, Sill H. Correspondence re: O. J. Arola et al., acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res 2000: 60: 1789-1792, Cancer Res 2001; 61: 2335-2336.
10. Zhou Z, Kang YJ. Immunocytochemical localization of metallothionein and its relation to doxorubicin toxicity in transgenic mouse heart. AM j PathoI 2000: 156: 1653-1662.
11. Wang L, MA W, Markovich R, Lee WL, Wang PH., Insulin-like growth factor I modulates induction of apoptotic signaling in H9C2 cardiac muscle cells. Endocrinology 1998: 139: 1354-1360.
12. Beanlands RSB, Shaikh NA, Wen WH, Dawood F, Ugnat AM, Mclaughlin PR, Carere R, Liu PP. Alterations in fatty acid metabolism in adriamycin cardiomyopathy. J Mol Cardiol 1994; 26: 109-119.
13. Kawasaki N, Lee JD, Shimizu H, Ishii Y, Ueda T. Cardiac energy metabolism at several stages of adriamycin-induced heart failure in rats. Int J Cardiol 1996: 55: 217-225.
14. Chen JJ, Hsu KH, Kao YC, Shin NL, Lien WP. Developmental regulation of myosin heavy chain gene expression in cultured rat cardiac muscle cells. Acta Cardiol Sin 1992; 8: 12-21.
15. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991: 139: 271-279.
16. Yamaoka M, Yamaguchi S, Suzuki T, Okuyama M, Nitobe J, Nakamura N, Mitsui Y, Tomoike H. Apoptosis in rat cardiac myocytes induced by Fas ligand: Priming for Fan-mediated apoptosis with doxorubicin. J Mol Cell Cardiol 2000: 32: 881-889,
17. Kotamraju S, Konorev EA, Joseph J, Kalyanaraman B, Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species. J Biol Chem 2000; 275: 33585-33592.
18. Negoro S, Oh H, Tone E, Kunisada K, Fujio Y, Walsh K, Kishimoto T, Yamauchi-Takihara K. Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and BcL-xL/caspase-3 interaction. Circulation 2001; 103: 555-561.
19. Muller C, Chatelut E, Gualano V, De Forni M, Huguet F, Attal M, Canal P, Laurent G. Cellular pharmacokinetics of doxorubicin in patients with chronic lymphocytic leukemia: Comparison of bolus administration and continuous infusion. Cancer Chemother Pharmacol 1993: 32: 379-384.
20. Arola OJ, Saraste A, Pulkki K, Kallajoki M, Parvinen M, Voipio-Pulkki LM. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res 2000: 60: 1789-1792.
21. Zhang J, Clark JR, Herman EH, Ferrans VJ. Doxorubicin-induced apoptosis in spontaneously hypertensive rats: Differential effects in heart, kidney and intestine, and inhibition by ICRF-187. J Mol Cell Cardiol 1996; 28: 1931-1943.
22. Nakamura T, Ueda Y, Juan Y, Katsuda S, Takahashi H, Koh E. Fas-mediated apoptosis in adriamycin-induced cardiomyopathy in rats: In vivo study. Circulation 2000; 102: 572-578.
23. Vescovo G, Zennaro R, Sandri M, Carraro U, Leprotti C, Ceconi C, Ambrosio GB, Dalla Liberal L. Apoptosis of skeletal muscle myofibers and interstitial cells in experimental heart failure. J Mol Cell Cardiol 1998; 30: 2449-2459.
24. Cesselli D, Jakoniuk I, Barlucchi L, Beltrami AP, Hintze TH, Nadal-Ginard B, Kajstura J, Leri A, Anversa P. Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res 2001; 89: 279-286.
25. Pulkki KJ. Cytokines and cardiomyocyte death. Ann Med 1997: 29: 339-343.
26. Darville MI, Eizirik DL. Cytokine induction of Fas gene expression in insulin-producing cells requires the transcription factors NF-kappaB and C/EBP. Diabetes 2001: 50: 1741-1748.
27. Rossig L, Haendeler J, Mallat Z, Hugel B, Freyssinet JM, Tedgui A, Dimmeler S, Zeiher AM. Congestive heart failure induces endothelial cell apoptosis: Protective role of carvedilol. J Am Coll Cardiol 2000; 36: 2081-2089.
28. Hare JM. Oxidative stress and apoptosis in heart failure progression. Circ Res 2001: 89: 198-200.
29. Scarabelli T, Stephanou A, Rayment N, Pasini E, Comini L, Curello S, Ferrari R, Knight R, Latchman D. Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation 2001: 104: 253-256.
30. Kang YJ, Zhou ZX, Wang GW, Buridi A, klein JB. Suppression by metallothionein of doxorubicin-induced cardiomyocyte apoptosis through inhibition of p38 mitogen-activated protein kinases. J Biol Chem 2000: 275: 13690-13698.
31. Wang L, Maw, Markovich R, Chen JW, Wang PH. Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I. Circ Res 1998: 83: 516-522.